New Filings & Updated Terms (2.2.19)

NEW FILINGS

TERMS ADDED

Company: Alector, Inc.
Symbol: ALEC
Description: They are a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration.
Shares: 9.25 million
Price Range: $18.00-$20.00
Trade Date: 2/7
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays
Terms Added: 1-29-19

Company: Harpoon Therapeutics, Inc.
Symbol: HARP
Description: They are a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.
Shares: 5.4 million
Price Range: $13.00-$15.00
Trade Date: 2/8
Underwriter(s): Citigroup, SVB Leerink
Co-Manager(s): Canaccord Genuity, Wedbush PacGrow
Terms Added: 1-29-19

Company: Virgin Trains USA Inc.
Symbol: VTUS
Description: They own and operate an express passenger rail system connecting major population centers in Florida, with plans to expand operations further in Florida, Las Vegas and elsewhere in North America.
Shares: 28.3 million
Price Range: $17.00-$19.00
Trade Date: 2/13
Underwriter(s): Barclays, J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Allen & Co.
Co-Manager(s): JMP Securities, Raymond James, Stephens Inc.
Terms Added: 1-30-19

Company: Anchiano Therapeutics Ltd.
Symbol: ANCN
Description: They are a clinical-stage biotechnology company committed to engineering a targeted gene therapy to improve the standard treatment for early-stage bladder cancer, which is one of the most prevalent forms of cancer. Their ordinary shares are listed on the Tel Aviv Stock Exchange Ltd., or the TASE, under the symbol “ANCN”.
Shares: 2.4 million ADSs
Price Range: $14.55-$14.55
Trade Date: 2/12
Underwriter(s): Oppenheimer & Co.
Co-Manager(s): Ladenburg Thalmann
Terms Added: 1-31-19